These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34210953)

  • 1. Highly efficient gene editing and single cell analysis of hematopoietic stem/progenitor cells from X-linked sideroblastic anemia patients.
    Fang R; Zhang J; Yang H; Shi J; Zeng H; Zhu X; Wei D; Yuan P; Cheng T; Zhang Y
    Signal Transduct Target Ther; 2021 Jul; 6(1):248. PubMed ID: 34210953
    [No Abstract]   [Full Text] [Related]  

  • 2. Raab SO, Haut A, Cartwright GE, Wintrobe MM. Pyridoxine-responsive anemia. Blood. 1961;18(3):285-302.
    Blood; 2016 May; 127(20):2365. PubMed ID: 27207318
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in the ALAS2 gene from patients with X-linked sideroblastic anemia.
    Li J; Chen L; Lin Y; Ru K
    Int J Lab Hematol; 2020 Aug; 42(4):e160-e163. PubMed ID: 32297424
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case report of X-linked sideroblastic anemia with novel ALAS2 gene mutation].
    Bao SJ; Zhu HM; Tong Y; Hao D; Ling Y; Yuan W; Zhou Y; Sun ZQ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):684. PubMed ID: 31495138
    [No Abstract]   [Full Text] [Related]  

  • 6. A synonymous coding variant that alters ALAS2 splicing and causes X-linked sideroblastic anemia.
    Oakley JH; Campagna DR; Sun L; Rockowitz S; Sliz P; Boudreaux J; Woods G; Fleming MD
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29309. PubMed ID: 34411431
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
    Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
    Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine.
    Ducamp S; Sendamarai AK; Campagna DR; Chin DWL; Fujiwara Y; Schmidt PJ; Fleming MD
    Blood; 2024 Sep; 144(13):1418-1432. PubMed ID: 38900972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel hemizygous I418S mutation in the ALAS2 gene in a young Korean man with X-linked sideroblastic anemia.
    Moon SY; Jun IJ; Kim JE; Lee SJ; Kim HK; Yoon SS
    Ann Lab Med; 2014 Mar; 34(2):159-62. PubMed ID: 24624355
    [No Abstract]   [Full Text] [Related]  

  • 10. Different haematological picture of congenital sideroblastic anaemia in a hemizygote and a heterozygote.
    Aguiar E; Freitas MI; Barbot J
    Br J Haematol; 2014 Aug; 166(4):469. PubMed ID: 24862439
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel mutation, Ile289Thr, in the ALAS2 gene in a family with pyridoxine responsive sideroblastic anaemia.
    Percy MJ; Cuthbert RJ; May A; McMullin MF
    J Clin Pathol; 2006 Sep; 59(9):1002. PubMed ID: 16935983
    [No Abstract]   [Full Text] [Related]  

  • 12. X-linked Sideroblastic Anemia in a Malay Boy With ALAS2 S568G Mutation.
    Susanto TAK; Bhattacharyya R
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):408-409. PubMed ID: 28644307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic mutations in the
    Colin E; Courtois G; Brouzes C; Pulman J; Rabant M; Rötig A; Taffin H; Lion-Lambert M; Fabrega S; Da Costa L; De Montalembert M; Salomon R; Hermine O; Couronné L
    Haematologica; 2021 Dec; 106(12):3202-3205. PubMed ID: 34407605
    [No Abstract]   [Full Text] [Related]  

  • 14. Lethal ALAS2 mutation in males X-linked sideroblastic anaemia.
    Rose C; Callebaut I; Pascal L; Oudin C; Fournier M; Gouya L; Lambilliotte A; Kannengiesser C
    Br J Haematol; 2017 Aug; 178(4):648-651. PubMed ID: 27292130
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia.
    Qiu Y; Cai H; Cui L; Liu YX; Wang YN; Li J; Cao XX
    Ann Hematol; 2020 Feb; 99(2):371-373. PubMed ID: 31848684
    [No Abstract]   [Full Text] [Related]  

  • 16. A Novel
    Lee JS; Gu J; Yoo HJ; Koh Y; Kim HK
    Ann Clin Lab Sci; 2017 May; 47(3):319-322. PubMed ID: 28667034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a cell model of X-linked sideroblastic anemia using genome editing.
    Kaneko K; Kubota Y; Nomura K; Hayashimoto H; Chida T; Yoshino N; Wayama M; Ogasawara K; Nakamura Y; Tooyama I; Furuyama K
    Exp Hematol; 2018 Sep; 65():57-68.e2. PubMed ID: 29908199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G.
    Sussman NL; Lee PL; Dries AM; Schwartz MR; Barton JC
    Acta Haematol; 2008; 120(3):168-73. PubMed ID: 19066423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation Analysis of X-linked Sideroblastic Anemia in a 12-Month-Old Boy by Massively Parallel Sequencing.
    Yu HJ; Lee YJ; Shim JW; Kim DS; Shim JY; Park MS; Woo HY; Park H; Jung HL; Kwon MJ
    Ann Lab Med; 2018 Jul; 38(4):389-392. PubMed ID: 29611395
    [No Abstract]   [Full Text] [Related]  

  • 20. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
    To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
    Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.